Skip to content View accessibility statement

Health Insurance (Pharmaceutical Benefit) (General Provisions) (No. 2) (Amendment No. 13) (Jersey) Order 2014

View PDF (237 KB)

Health Insurance (Pharmaceutical Benefit) (General Provisions) (No. 2) (Amendment No. 13) (Jersey) Order 2014

Made                                                                      28th October 2014

Coming into force                                                  1st December 2014

THE MINISTER FOR SOCIAL SECURITY, in pursuance of Articles 15 and 36 of the Health Insurance (Jersey) Law 1967[1], orders as follows –

1        Amendment of Schedule 4

For Part 2 of Schedule 4 to the Health Insurance (Pharmaceutical Benefit) (General Provisions) (No. 2) (Jersey) Order 2002[2] there shall be substituted the following Part –

“PART 2

 

Oral or transdermal medicine used for contraception and containing any of the following –

desogestrel

dienogest

drospirenone

estradiol hemihydrate

estradiol valerate

ethinylestradiol

gestodene

levonorgestel

mestranol

nomegestrol

norelgestromin

norgestimate

norethisterone”.

2        Citation and commencement

This Order may be cited as the Health Insurance (Pharmaceutical Benefit) (General Provisions) (No. 2) (Amendment No. 13) (Jersey) Order 2014 and shall come into force on 1st December 2014.

senator f. du h. le gresley

Minister for Social Security

 

 


[1]                                    chapter 26.500

[2]                                    chapter 26.500.22


Page Last Updated: 15 Apr 2016